Fucidic acid use in metronidazole nonresponders with Clostridium difficile infection [1]

Digestion

Volumn 75, Issue 4, 2007, Pages 177-178

  Bektaş, Mehmet ^a   Törüner, Murat ^a   Çetinkaya, Hülya ^a   Soykan, Irfan ^a   Özden, Ali ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; FUSIDIC ACID; METRONIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CHRONIC DIARRHEA; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; CROHN DISEASE; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; STATISTICAL SIGNIFICANCE; SYMPTOM; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CLOSTRIDIUM INFECTIONS; FEMALE; FUSIDIC ACID; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 36749043257     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106974     Document Type: Letter

References (13)

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB: Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298:531-534.
2. Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG: Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:345-351.
3. Greenfield C, Aguilar Ramirez JR, Pounder RE, Williams T, Danvers M, Marper SR, Noone P: Clostridium difficile and inflammatory bowel disease. Gut 1983;24:713-717.
4. Rolny P, Jarnerot G, Mollby R: Occurrence of Clostridium difficile toxin in inflammatory bowel disease. Scand J Gastroenterol 1983;18:61-64.
5. Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS: Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004;16:775-778.
6. Meyer AM, Ramzan NN, Loftus EV Jr, Heigh RI, Leighton JA: The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004;38:772-775.
7. Manatsathit S, Dupont HL, Farthing M, Kositchaiwat C, Leelakusolvong S, Ramakrishna BS, Sabra A, Speelman P, Surangsrirat S: Guideline for the management of acute diarrhea in adults. J Gastroenterol Hepatol 2002;17(suppl):S54-S71.
8. Schroeder MS: Clostridium difficile-associated diarrhea. Am Fam Physician 2005;71:921-928.
9. Oppenheimer M, Kronvall G, Karlsson I, Holst E: Fucidic acid disk diffusion testing of Clostridium difficile can be calibrated using single-strain regression analysis. Scand J Infect Dis 2000;32:633-636.
10. Wullt M, Odenholt I: A double-blind randomized controlled trial of fucidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea. J Antimicrob Chemother 2004;54:211-216.
11. Collignon P, Turnidge J: Fucidic acid in vitro activity. Int J Antimicrobial Agents 1999;12(suppl 2):S45-S58.
12. Oppenheimer M, Kronvall G, Karlsson I, et al: Fucidic acid disk diffusion testing of Clostridium difficile can be calibrated using single-strain regression analysis. Scand J Infect Dis 2000;32:633-636.
13. Cronberg S, Castor B, Thoren A: Fucidic acid for the treatment of antibiotic-associated colitis induced by Clostridium difficile. Infection 1984;12:276-279.